Pipeline Bioresearch ApS: Financial statements 2023
CVR: 37831735
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pipeline Bioresearch ApS (CVR 37831735) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -67,097 and a net result of DKK -170,538 compared with DKK -235,110 the year before. Equity in the 2023 report amounted to DKK 117,789. The solvency ratio was 45.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -67,097
- Profit/Loss
- DKK -170,538
- Equity
- DKK 117,789
- Total Assets
- DKK 256,477
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -67 t. | -171 t. | 118 t. | 1 |
| 2022 | 0 | -231 t. | -235 t. | 288 t. | - |
| 2021 | - | 1.4 mio. | 2 t. | 523 t. | - |
| 2020 | - | 1.6 mio. | 26 t. | 521 t. | - |
| 2019 | 2 mio. | 2 mio. | -17 t. | 501 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pipeline Bioresearch ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -235,110.
About Pipeline Bioresearch ApS
Pipeline Bioresearch ApS was a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2016. The company has been dissolved on 5 July 2024. The company was registered under the industry Ikke-finansielle holdingselskaber. The company has 2 employees (2021). In 2023, the company reported a gross profit of DKK -67,097 and a net result of DKK -170,538 compared with DKK -235,110 the year before. Equity in the 2023 report amounted to DKK 117,789.